Identification of Candidate Inhibitors to SARS-CoV-2's Enzymes and Potential Disruptors of Its Structural Proteins' Interactions. [PDF]
Mohammadian A +4 more
europepmc +1 more source
Targeting lipid droplets in the management of MASLD. [PDF]
Mikaeeli S, Cohen DE.
europepmc +1 more source
Safety and efficacy of different therapeutic regimens in Egyptian adults with moderate COVID-19 infection (EVEREST): a real-world retrospective study. [PDF]
Abdel-Salam Elgohary M +10 more
europepmc +1 more source
Antifibrotic Efficacy of Daclatasvir Against Pulmonary Fibrosis: Insights From Network Pharmacology, Molecular Docking, Dynamics, and Preclinical Evaluations. [PDF]
Patil KS +6 more
europepmc +1 more source
Genetic Characterization of Hepatitis C Virus Among People Who Use Crack Cocaine: A Study Conducted on the Brazilian Amazon Coast. [PDF]
Heymbeeck JAA +11 more
europepmc +1 more source
Sensitive RP-HPLC method with fluorimetric detection for concurrent quantification of emtricitabine, Daclatasvir and Ledipasvir in human urine. [PDF]
Youssef AA +3 more
europepmc +1 more source
Are Direct-Acting Antivirals Effective and Safe for Hepatitis C Patients with Arterial Hypertension? Evidence from a Large Retrospective Real-World Study. [PDF]
Brzdęk M +11 more
europepmc +1 more source
The effect of HFE gene mutation and iron overload on sustained virological response in Egyptian chronic hepatitis C patients treated with daclatasvir and sofosbuvir. [PDF]
Kodsi EM +6 more
europepmc +1 more source
Evaluating long-term outcomes of direct-acting antiviral therapy in chronic hepatitis C: A retrospective study. [PDF]
Sung BR +7 more
europepmc +1 more source

